4/A: OptimizeRx CFO Corrects Stock Transaction Reporting Error in Amended SEC Filing
SEC Filing Amendment
Edward Stelmakh, CFO/COO of OptimizeRx Corp, files an amended SEC Form 4/A to correct an understatement of shares acquired and holdings following a restricted stock unit vesting.
Summary
- Edward Stelmakh, the CFO/COO of OptimizeRx Corp, filed an amended Form 4/A with the SEC.
- The amendment corrects an error in the original Form 4 filed on October 12, 2023, regarding the number of shares acquired upon the vesting of a restricted stock unit on October 11, 2023.
- The original filing inadvertently understated the number of shares acquired and, consequently, the reporting person's holdings following the transaction.
- The correct amount of shares disposed of in connection with such vesting was correctly reported in Table II of the Original Form 4.
- This amended filing corrects the understatement in Table I and adjusts the reported holdings.
- Subsequent Forms 4 will also reflect these corrections.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. The document addresses a reporting error and takes corrective action, which is a responsible approach. However, the initial error could raise minor concerns.
Positives
- The company is taking steps to correct errors in previous filings, demonstrating transparency.
- The error was identified and corrected relatively quickly.
Negatives
- The original Form 4 contained an error, which could raise concerns about the accuracy of financial reporting.
- The understatement affected the holdings reported after subsequent transactions in the Original Form 4 and in subsequently filed Forms 4.
Risks
- Continued errors in SEC filings could lead to regulatory scrutiny.
- Inaccurate reporting may erode investor confidence.
Industry Context
SEC filings related to stock transactions are a routine part of corporate governance and are closely monitored by investors for insights into executive compensation and ownership.
Stakeholder Impact
- Shareholders will benefit from the corrected information, ensuring accurate reporting of executive holdings.
- The correction helps maintain investor confidence in the company's financial reporting.
Next Steps
- Subsequent Forms 4 will be updated to reflect the corrected holdings.
Key Dates
| Date | Description |
|---|---|
| 10/11/2023 | Date of the restricted stock unit vesting. |
| 10/12/2023 | Date of the original Form 4 filing containing the error. |
| 04/22/2024 | Date of the amended Form 4/A filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.